A Translational Approach to Addressing COVID‑19
We support research activities spanning the translational science spectrum to address COVID-19. With the aim of accelerating translational research across all diseases, we developed research tools, technologies, expertise and collaborative networks that can quickly pivot to address urgent public health issues.
A Translational Approach to Addressing COVID-19
The process of developing new therapies and getting them to patients is long and difficult. During public health emergencies, science — and the process of turning observations into new therapies — must move faster than ever. That is where translational science comes in.
Translational science is focused on streamlining the process of moving (“translating”) lab findings into medical practice and treatments to improve health and well-being. We are concentrating on advancing the science of translation.
By using our networks to draw together experts with necessary and complementary skills, knowledge and experience, we enable projects to cut through operational roadblocks.
Learn about projects that are leveraging existing platform approaches to help detect coronavirus cases and find ways to treat infection.
The NIH-Led Research Response to COVID-19
NCATS News — Feb. 2, 2023
NCATS staff members joined leaders from NIH and partner organizations to co-author a Science Policy Forum on the NIH-led research response to COVID-19, key milestones and lessons learned.
COVID-19 Hospitalization May Increase Heart Failure Risk
NCATS News — Oct. 6, 2022
Previous Common Colds Could Boost Risks of More Severe COVID-19
NCATS News — Sept. 29, 2022
Tiny Antibodies May Provide New Tool to Fight COVID-19
NCATS News — Aug. 30, 2022